Atlas Trials

Study to Predict Lanreotide-induced Disease Activity Normalization in Acromegaly

Clinical trial NCT04003519 · WITHDRAWN

Trial details

NCT number
NCT04003519
Sponsor
Ipsen
Status
WITHDRAWN
Study type
OBSERVATIONAL
Acromegaly
Start date
2020-04-01
Primary completion
2023-06-30
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.